Drugs / UMSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04763369 | Feb 2021 → May 2022 | retinitis pigmentosa | Jinnah Burn and Reconstructive Surgery Centre, Lahore | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UMSCs | “It is well documented that umbilical cord derived mesenchymal stem cells (UMSCs) have the ability to release various paracrine and immunomodulatory factors that are similar to...” NCT04763369 ↗ |
| Known as | umbilical cord derived mesenchymal stem cells | “It is well documented that umbilical cord derived mesenchymal stem cells (UMSCs) have the ability to release various paracrine and immunomodulatory factors that are similar to...” NCT04763369 ↗ |
| Route | Other | “UMSC injection employing two different routes (sub-tenon injection versus suprachoroidal injection)” NCT04763369 ↗ |